ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,680.02
1.26%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Bausch plus Lomb Corporation (BLCO)

  7. Bausch plus Lomb Corporation (BLCO) Noticias

BLCO Bausch plus Lomb Corporation

13.26
-0.60 (-4.33%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Bausch plus Lomb Corporation BLCO NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.60 -4.33% 13.26 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
14.04 13.53 14.35 13.60 13.86
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202405:58BWBausch + Lomb Announces First-Quarter 2024 Results
29/4/202406:00BWBausch + Lomb Announces Presentation of New Data at the..
25/4/202407:30BWBausch + Lomb Announces Statistically Significant Results..
18/4/202406:00BWBausch + Lomb Reports More Than 84 Million Units of Contact..
15/4/202411:00BWBausch + Lomb Will Release First-Quarter 2024 Financial..
27/3/202406:00BWBausch + Lomb Will Present New Scientific Data and Analyses..
04/3/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202407:12EDGAR2Form 8-K - Current report
28/2/202407:00BWBausch + Lomb Announces Appointment of Karen L. Ling to..
21/2/202406:00EDGAR2Form 8-K - Current report
21/2/202406:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
21/2/202405:58BWBausch + Lomb Announces Fourth-Quarter and Full-Year 2023..
05/2/202411:00BWBausch + Lomb Will Release Fourth-Quarter and Full-Year 2023..
08/1/202405:59BWBausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser..
03/1/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202408:00BWBausch + Lomb to Participate in the 42nd Annual J.P. Morgan..
15/11/202305:59BWBausch + Lomb Reports More Than 76 Million Units of Contact..
13/11/202315:47EDGAR2Form 8-K/A - Current report: [Amend]
07/11/202316:00EDGAR2Form 8-K/A - Current report: [Amend]
01/11/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202306:02EDGAR2Form 8-K - Current report
01/11/202305:58BWBausch + Lomb Announces Third-Quarter 2023 Results and..
26/10/202305:59BWBausch + Lomb Will Present New Scientific Data and Analyses..
16/10/202311:00BWBausch + Lomb Will Release Third-Quarter 2023 Financial..
04/10/202305:59BWBausch + Lomb Will Present New Scientific Data and Analyses..
03/10/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202315:24EDGAR2Form 8-K - Current report
29/9/202309:00BWBausch + Lomb Completes Acquisition of XIIDRA®
26/9/202305:59BWBausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the..
20/9/202305:59BWBausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling..
14/9/202316:26EDGAR2Form 8-K - Current report
14/9/202316:25BWBausch + Lomb Announces Pricing of Senior Secured Notes..
12/9/202305:59BWBausch + Lomb Launches MIEBO™ (Perfluorohexyloctane..
11/9/202306:22EDGAR2Form 8-K - Current report
11/9/202306:07BWBausch + Lomb Announces Launch of Proposed Financing for..
06/9/202316:58BWBausch + Lomb Announces Disclosure of Historical and Pro..
06/9/202316:28EDGAR2Form 8-K - Current report
06/9/202305:59BWBausch + Lomb Will Present New Scientific Data on its..
29/8/202316:05EDGAR2Form 8-K/A - Current report: [Amend]
29/8/202306:00BWBausch + Lomb Will Participate at the 2023 Wells Fargo..
24/8/202306:00BWBausch + Lomb Announces Expiration of Hart-Scott-Rodino..
02/8/202316:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/8/202316:09EDGAR2Form S-3ASR - Automatic shelf registration statement of..
02/8/202315:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente

NYSE
BLCO
Bausch plus Lomb
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados